Pomanda estimates the enterprise value of EPHARMIT LIMITED at £4.5m based on a Turnover of £21.7m and 0.21x industry multiple (adjusted for size and gross margin).
epharmit limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of EPHARMIT LIMITED at £0 based on an EBITDA of £-48.1k and a 4.39x industry multiple (adjusted for size and gross margin).
epharmit limitedEstimated Valuation
£2.7m
Pomanda estimates the enterprise value of EPHARMIT LIMITED at £2.7m based on Net Assets of £2.2m and 1.21x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Epharmit LimitedOverview
Epharmit Limited is a live company located in dudley, DY1 4RH with a Companies House number of 07041582. It operates in the temporary employment agency activities sector, SIC Code 78200. Founded in October 2009, it's largest shareholder is
stuart hughes
with a 50% stake. Epharmit Limited is a established,
large sized company, Pomanda has estimated its turnover at
£21.7m with
rapid
growth in recent years.
Pomanda's financial health check has awarded Epharmit Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
7 Strong
2 Regular
2 Weak
Size
annual sales of £21.7m, make it larger than the average company (£13.4m)
£21.7m - Epharmit Limited
£13.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 33%, show it is growing at a faster rate (8%)
33% - Epharmit Limited
8% - Industry AVG
Production
with a gross margin of 18.3%, this company has a comparable cost of product (18.3%)
18.3% - Epharmit Limited
18.3% - Industry AVG
Profitability
an operating margin of -0.6% make it less profitable than the average company (2.5%)
-0.6% - Epharmit Limited
2.5% - Industry AVG
Employees
with 2 employees, this is below the industry average (49)
2 - Epharmit Limited
49 - Industry AVG
Pay Structure
on an average salary of £49.3k, the company has an equivalent pay structure (£49.3k)
£49.3k - Epharmit Limited
£49.3k - Industry AVG
Efficiency
resulting in sales per employee of £10.9m, this is more efficient (£232.9k)
£10.9m - Epharmit Limited
£232.9k - Industry AVG
Debtor Days
it gets paid by customers after 31 days, this is earlier than average (43 days)
31 days - Epharmit Limited
43 days - Industry AVG
Creditor Days
its suppliers are paid after 17 days, this is slower than average (3 days)
17 days - Epharmit Limited
3 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Epharmit Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 61 weeks, this is more cash available to meet short term requirements (7 weeks)
61 weeks - Epharmit Limited
7 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 28.8%, this is a lower level of debt than the average (70.2%)
28.8% - Epharmit Limited
70.2% - Industry AVG
EPHARMIT LIMITED financials
EXPORT
Epharmit Limited's latest turnover from March 2024 is estimated at £21.7 million and the company has net assets of £2.2 million. According to their latest financial statements, Epharmit Limited has 2 employees and maintains cash reserves of £1 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Turnover
21,718,612
12,592,399
11,095,531
9,261,694
10,690,320
10,000,450
8,917,139
9,307,929
9,260,701
7,614,285
5,812,368
3,093,523
2,444,414
4,325,741
Other Income Or Grants
Cost Of Sales
17,752,276
10,360,815
9,298,124
7,841,297
8,895,940
8,308,821
7,353,574
7,701,003
7,699,403
6,308,335
4,767,005
2,546,209
2,013,549
3,517,618
Gross Profit
3,966,335
2,231,584
1,797,407
1,420,397
1,794,380
1,691,629
1,563,564
1,606,927
1,561,299
1,305,950
1,045,363
547,313
430,865
808,123
Admin Expenses
4,104,949
2,301,497
1,665,754
1,138,964
1,423,785
1,378,836
1,264,805
1,227,352
1,286,398
1,099,786
818,037
438,073
329,625
615,281
Operating Profit
-138,614
-69,913
131,653
281,433
370,595
312,793
298,759
379,575
274,901
206,164
227,326
109,240
101,240
192,842
Interest Payable
Interest Receivable
68,452
73,375
13,833
1,555
1,095
5,976
2,794
1,363
2,810
2,028
1,300
818
715
368
Pre-Tax Profit
-70,162
3,462
145,486
282,988
371,690
318,769
301,553
380,938
277,711
208,192
228,626
110,058
101,955
193,210
Tax
-658
-27,642
-53,768
-70,621
-60,566
-57,295
-76,187
-55,542
-43,720
-52,584
-26,414
-26,508
-54,099
Profit After Tax
-70,162
2,804
117,844
229,220
301,069
258,203
244,258
304,750
222,169
164,472
176,042
83,644
75,447
139,111
Dividends Paid
Retained Profit
-70,162
2,804
117,844
229,220
301,069
258,203
244,258
304,750
222,169
164,472
176,042
83,644
75,447
139,111
Employee Costs
98,576
97,786
89,202
81,914
82,518
77,859
77,402
77,047
1,364,911
1,044,043
785,438
445,063
326,023
562,725
Number Of Employees
2
2
2
2
2
2
2
2
36
28
21
12
9
16
EBITDA*
-48,073
-32,691
195,695
324,663
436,675
357,695
345,070
388,700
284,579
207,834
229,448
111,639
102,109
193,268
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Tangible Assets
238,299
31,939
134,831
155,235
125,030
191,110
171,112
147,368
23,309
1,504
167
1,957
443
425
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
238,299
31,939
134,831
155,235
125,030
191,110
171,112
147,368
23,309
1,504
167
1,957
443
425
Stock & work in progress
Trade Debtors
1,878,495
1,207,291
850,927
650,607
1,020,873
971,412
1,005,318
1,025,489
614,669
508,160
412,860
250,812
193,854
255,481
Group Debtors
Misc Debtors
Cash
1,003,542
1,604,153
1,848,784
1,840,124
1,269,193
921,351
672,212
445,584
644,621
479,575
331,646
188,286
139,043
147,049
misc current assets
40,000
total current assets
2,922,037
2,811,444
2,699,711
2,490,731
2,290,066
1,892,763
1,677,530
1,471,073
1,259,290
987,735
744,506
439,098
332,897
402,530
total assets
3,160,336
2,843,383
2,834,542
2,645,966
2,415,096
2,083,873
1,848,642
1,618,441
1,282,599
989,239
744,673
441,055
333,340
402,955
Bank overdraft
Bank loan
Trade Creditors
851,888
516,363
492,693
418,084
422,173
379,464
406,236
423,330
417,050
350,521
270,427
142,851
118,780
263,842
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
851,888
516,363
492,693
418,084
422,173
379,464
406,236
423,330
417,050
350,521
270,427
142,851
118,780
263,842
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
59,575
7,985
25,618
29,495
23,756
36,311
32,511
29,474
4,662
total long term liabilities
59,575
7,985
25,618
29,495
23,756
36,311
32,511
29,474
4,662
total liabilities
911,463
524,348
518,311
447,579
445,929
415,775
438,747
452,804
421,712
350,521
270,427
142,851
118,780
263,842
net assets
2,248,873
2,319,035
2,316,231
2,198,387
1,969,167
1,668,098
1,409,895
1,165,637
860,887
638,718
474,246
298,204
214,560
139,113
total shareholders funds
2,248,873
2,319,035
2,316,231
2,198,387
1,969,167
1,668,098
1,409,895
1,165,637
860,887
638,718
474,246
298,204
214,560
139,113
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Operating Activities
Operating Profit
-138,614
-69,913
131,653
281,433
370,595
312,793
298,759
379,575
274,901
206,164
227,326
109,240
101,240
192,842
Depreciation
90,541
37,222
64,042
43,230
66,080
44,902
46,311
9,125
9,678
1,670
2,122
2,399
869
426
Amortisation
Tax
-658
-27,642
-53,768
-70,621
-60,566
-57,295
-76,187
-55,542
-43,720
-52,584
-26,414
-26,508
-54,099
Stock
Debtors
671,204
356,364
200,320
-370,266
49,461
-33,906
-20,171
410,820
106,509
95,300
162,048
56,958
-61,627
255,481
Creditors
335,525
23,670
74,609
-4,089
42,709
-26,772
-17,094
6,280
66,529
80,094
127,576
24,071
-145,062
263,842
Accruals and Deferred Income
Deferred Taxes & Provisions
51,590
-17,633
-3,877
5,739
-12,555
3,800
3,037
24,812
4,662
Cash flow from operations
-332,162
-383,676
38,465
642,811
346,747
308,063
293,889
-67,215
193,719
148,908
142,392
52,338
-7,834
147,530
Investing Activities
capital expenditure
-296,901
65,670
-43,638
-73,435
-64,900
-70,055
-133,184
-31,483
-3,007
-332
-3,913
-887
-851
Change in Investments
cash flow from investments
-296,901
65,670
-43,638
-73,435
-64,900
-70,055
-133,184
-31,483
-3,007
-332
-3,913
-887
-851
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
2
interest
68,452
73,375
13,833
1,555
1,095
5,976
2,794
1,363
2,810
2,028
1,300
818
715
368
cash flow from financing
68,452
73,375
13,833
1,555
1,095
5,976
2,794
1,363
2,810
2,028
1,300
818
715
370
cash and cash equivalents
cash
-600,611
-244,631
8,660
570,931
347,842
249,139
226,628
-199,037
165,046
147,929
143,360
49,243
-8,006
147,049
overdraft
change in cash
-600,611
-244,631
8,660
570,931
347,842
249,139
226,628
-199,037
165,046
147,929
143,360
49,243
-8,006
147,049
epharmit limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for epharmit limited. Get real-time insights into epharmit limited's credit score, group structure and payment trends.
Perform a competitor analysis for epharmit limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other large companies, companies in DY1 area or any other competitors across 12 key performance metrics.
epharmit limited Ownership
EPHARMIT LIMITED group structure
Epharmit Limited has no subsidiary companies.
Ultimate parent company
EPHARMIT LIMITED
07041582
EPHARMIT LIMITED Shareholders
The largest shareholders in Epharmit Limited include Stuart Hughes and Heather Catherine Elizabeth Hughes.
stuart hughes
50%
heather catherine elizabeth hughes
50%
epharmit limited directors
Epharmit Limited currently has 2 directors.
The longest serving directors include
Ms Heather Hughes (Oct 2009) and
Mr Stuart Hughes (Jun 2012).
no 4 castle court 2, castlegate way, dudley, west midlands, DY1 4RH
Bank
-
Legal Advisor
-
epharmit limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to epharmit limited.
epharmit limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for EPHARMIT LIMITED. This can take several minutes, an email will notify you when this has completed.
epharmit limitedCompanies House Filings - See Documents
